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Introduction

Results

Discussion

• Alzheimer’s Disease (AD) is a form of progressive
dementia that affects 5.3 million Americans and is the
sixth leading cause of death in the US.
• Age is a major risk factor for disease , and 1 in 8
Americans over 65 can expect to develop AD.
• The U.S. healthcare system spends $172 billion/year on
patients with AD and dementia, more than half of the
Medicare budget. This cost is estimated to increase to
over $1 trillion by 2050.
• In 2003, the US Preventative Services Task Force
(USPSTF) concluded that screening older adults for
dementia is ineffective due to insufficient means of
preventing or slowing its progression.
• In 2011, the National Institute on Aging published new
diagnostic criteria for AD.
• In accordance with these guidelines the Centers for
Medicare and Medicaid Services released rules for the
new Annual Wellness Visit that include the detection of
cognitive impairment.
• Our goal was to identify the attitudes and practices of
primary care physicians (PCPs) in Vermont (VT)
related to screening for AD and dementia.

Physician reported reasons why early detection of
AD is not important*

• 78% of PCPs believe that there are reasons why early
detection of AD is not important; of those, 87% cite no
effective treatment or cure as the main reason. Those
94% of PCPs who think that it can be important believe
that the most important reason for early detection is to
provide support and resources for the patient and
family.
• Focus group members felt that regardless of a cure, a
diagnosis is essential in order to learn about and find
ways to live happily with their disease, and stressed the
importance of an early diagnosis in initiating support
groups and family planning.
• While the most common reason why physicians don’t
always screen for AD is due to other medical issues that
are more pressing, caregivers and patients believe that
cognitive status should be addressed in every
appointment because it’s an everyday struggle.

Methods
Survey:
• A survey was distributed to 280 PCPs throughout VT
by email or fax; 63 surveys were completed.
• 19 multiple choice questions assessed practices and
attitudes relating to the screening, early detection, and
diagnosis of AD and dementia.
• Data was analyzed using Microsoft Excel.
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Physician reported reasons why early detection
of AD is important *

“The medical
establishment doesn’t
think it makes a difference
in terms of medication,
but it makes a difference
to the patient. I didn’t
know what was wrong,
and that was scary.
Having the diagnosis was
a big help for me,
personally.”
- Focus Group Participant
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Tendency of physicians to screen older patients
for AD during their annual wellness visit

Age of patient at which physicians first
consider a clincial diagnosis of AD

Do you encourage family members to attend
encounters with your elderly patients?
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Focus Group:
• Patients with AD and other forms of dementia, and
their caregivers, attended a 2-hour focus group.
• 13 participants provided their perspectives on the
benefit and/or harm of early detection of AD and
dementia and shared their personal experiences.

“Even if they don’t have a
lot of medication for me, I
can make a new normal.
Adjusting to that is what I
need to do, not focus on
what I can’t do….One
piece of information can
make the difference in a
family’s whole life”
- Focus Group Participant
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Conclusion
• The USPSTF statement that there is insufficient
evidence to recommend routine screening for dementia
has caused controversy in the medical community.
• We have found that PCPs in VT are reluctant to
routinely screen for AD and dementia, in large part due
to the perception that early diagnosis of AD in the
absence of a cure serves no purpose.
• Our interactions with patients and their caregivers
taught us that experiencing cognitive decline without a
diagnosis is extraordinarily distressing; the diagnosis
itself facilitates acceptance of a “new normal” and
enables adaptation to life with AD or other dementia.
• We conclude that screening and early intervention for
AD and dementia are extremely important. We
encourage PCPs to be proactive in screening so that
patients can plan, and maintain quality of life, prior to
the onset of late-stage disease.
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